Company Overview and News

0
Atlantic Power Corp's (AT) CEO Jim Moore on Q2 2018 Results - Earnings Call Transcript

2018-08-03 seekingalpha
Atlantic Power Corporation (NYSE:AT) Q2 2018 Results Earnings Conference Call August 3, 2018 8:30 PM ET
COMD ATP AT APRWF

0
Martin Midstream Partners (MMLP) CFO, Robert Bondurant on Q2 2018 Results - Earnings Call Transcript

2018-07-26 seekingalpha
Martin Midstream Partners LP (NASDAQ:MMLP) Q2 2018 Earnings Conference Call July 26, 2018 9:00 AM ET
COMD MMLP

21
Napo Pharmaceuticals to Present New Data at the 22nd International AIDS 2018 Conference

2018-07-16 accesswire
Presentation Will Cover New Data on the Incidence and Prevalence of Diarrhea in HIV Clinical Trials in the Recent Post-Combined Antiretroviral Therapy (cART) Era
JAGX COMD

1
Vermillion Names Chris Goulart to Senior Vice President of Commercial Operations

2018-06-13 globenewswire
AUSTIN, Texas, June 13, 2018 (GLOBE NEWSWIRE) -- Vermillion, Inc. (NASDAQ:VRML), a bio-analytical solutions company focused on gynecologic disease, today announced that Mr. Chris Goulart has been appointed as Senior Vice President of Commercial Operations, a newly created position focusing on the Company’s growth operations.
COMD VRML

0
GENFIT: Announces the Nomination of Pascal Prigent as Executive Vice President Marketing and Commercial Development

2018-05-31 globenewswire
Lille (France), Cambridge (Massachusetts, United States), May 31, 2018 - GENFIT (Euronext: GNFT - ISIN: FR0004163111), a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic and inflammatory diseases, that notably affect the liver or the gastrointestinal system, today announced it has appointed M. Pascal Prigent as Executive Vice President Marketing and Commercial Development.
COMD

43
CEOs, Directors and Other Senior Executives Tapped by Biotech

2018-05-22 biospace
Pharma and biotech companies across the globe continued to expand and reshape their leadership teams with new hires this past week. BioSpace collected several announced leadership appointments, which includes new chief executive officers, new members to boards of directors and more.
SGEN RCKT COMD GILD UBX ABEO ABEOW

81
Pulse Biosciences' (PLSE) CEO Darrin Uecker on Q1 2018 Results - Earnings Call Transcript

2018-05-11 seekingalpha
Good afternoon. My name is Julie and I will be your conference operator today. At this time, I would like to welcome everyone to the Pulse Biosciences Investor Update Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session [Operator Instructions].
COMD PLSE

3
Atlantic Power Corp's (AT) CEO Jim Moore on Q1 2018 Results - Earnings Call Transcript

2018-05-04 seekingalpha
Atlantic Power Corporation (NYSE:AT) Q1 2018 Results Earnings Conference Call May 4, 2018 8:30 AM ET
COMD ATP AT APRWF

3
Martin Midstream Partners' (MMLP) Management on Q1 2018 Results - Earnings Call Transcript

2018-04-26 seekingalpha
Martin Midstream Partners LP (NASDAQ:MMLP) Q1 2018 Earnings Conference Call April 26, 2018 9:00 AM ET
COMD MMLP

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...